Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Liver Cirrhosis"" wg kryterium: Temat


Tytuł:
Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis.
Autorzy:
Ao X; Department of Gastroenterology and Hepatology and Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital, Sichuan University, Sichuan, China.
Zeng Y; Department of Gastroenterology and Hepatology and Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital, Sichuan University, Sichuan, China.
Wang X; Department of Gastroenterology and Hepatology and Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital, Sichuan University, Sichuan, China.
Fan X; Department of Gastroenterology and Hepatology and Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital, Sichuan University, Sichuan, China.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jul; Vol. 60 (1), pp. 105-106. Date of Electronic Publication: 2024 May 27.
Typ publikacji:
Letter
MeSH Terms:
Liver Cirrhosis, Biliary*/drug therapy
Liver Cirrhosis, Biliary*/complications
Humans ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/complications ; Cholangitis/drug therapy ; Hypolipidemic Agents/therapeutic use ; Hypolipidemic Agents/adverse effects ; Fibric Acids/therapeutic use ; Treatment Outcome
Opinia redakcyjna
Tytuł:
Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply.
Autorzy:
Burghart L; Klinik Ottakring, Wiener Gesundheitsverbund, Vienna, Austria.; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria.
Hofer BS; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Halilbasic E; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Simbrunner B; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Staettermayer AF; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Trauner M; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Reiberger T; Rare Liver Diseases (RALID) Center of the ERN RARE-LIVER at the Vienna General Hospital, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jul; Vol. 60 (1), pp. 107-108. Date of Electronic Publication: 2024 May 27.
Typ publikacji:
Letter
MeSH Terms:
Liver Cirrhosis*/drug therapy
Liver Cirrhosis*/complications
Humans ; Liver Cirrhosis, Biliary/drug therapy ; Liver Cirrhosis, Biliary/complications ; Hypolipidemic Agents/therapeutic use ; Hypolipidemic Agents/adverse effects ; Fibric Acids/therapeutic use ; Cholangitis/drug therapy
Opinia redakcyjna
Tytuł:
How does alcohol use impact morbidity and mortality of liver cirrhosis? A systematic review and dose-response meta-analysis.
Autorzy:
Llamosas-Falcón L; Institute for Mental Health Policy Research, Center for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, ON, M5S 2S1, Canada. .
Probst C; Institute for Mental Health Policy Research, Center for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, ON, M5S 2S1, Canada.; Heidelberg Institute of Global Health, Medical Faculty and University Hospital, Neuenheimer Feld 365, 69120, Heidelberg, Germany.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, ON, M5T 2S1, Canada.; Department of Psychiatry, University of Toronto, 250 College Street, Toronto, ON, M5T 1R8, Canada.
Buckley C; Department of Automatic Control and Systems Engineering, University of Sheffield, Mappin Street, Sheffield, S1 3JD, UK.
Jiang H; Institute for Mental Health Policy Research, Center for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, ON, M5S 2S1, Canada.; Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, ON, M5T 1P8, Canada.
Lasserre AM; Institute for Mental Health Policy Research, Center for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, ON, M5S 2S1, Canada.; Addiction Medicine, Department of Psychiatry, Lausanne University Hospital, Rue du Bugnon 23, 1011, Lausanne, Switzerland.
Puka K; Institute for Mental Health Policy Research, Center for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, ON, M5S 2S1, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, ON, M5T 2S1, Canada.; Department of Epidemiology and Biostatistics, Western University, 1465 Richmond St, London, ON, N6G 2M1, Canada.
Tran A; Institute for Mental Health Policy Research, Center for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, ON, M5S 2S1, Canada.
Zhu Y; Alcohol Research Group, Public Health Institute, 6001 Shellmound St #450 Emeryville, California, 94608, USA.
Rehm J; Institute for Mental Health Policy Research, Center for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, ON, M5S 2S1, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, ON, M5T 2S1, Canada.; Department of Psychiatry, University of Toronto, 250 College Street, Toronto, ON, M5T 1R8, Canada.; Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, ON, M5T 1P8, Canada.; Program On Substance Abuse & WHO CC, Public Health Agency of Catalonia, 81-95 Roc Boronat St. 8005, Barcelona, Spain.; Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.; Institute of Medical Science, Faculty of Medicine, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada.
Pokaż więcej
Źródło:
Hepatology international [Hepatol Int] 2024 Feb; Vol. 18 (1), pp. 216-224. Date of Electronic Publication: 2023 Sep 08.
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article
MeSH Terms:
Alcohol Drinking*/adverse effects
Alcohol Drinking*/epidemiology
Liver Cirrhosis*/etiology
Humans ; Risk Factors ; Morbidity ; Liver Cirrhosis, Alcoholic
Czasopismo naukowe
Tytuł:
Liver-targeted nanoparticles delivering nitric oxide reduce portal hypertension in cirrhotic rats.
Autorzy:
Perramón M; Biochemistry and Molecular Genetics Service, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain. Electronic address: .
Navalón-López M; Grup d'Enginyeria de Materials (Gemat), Institut Químic de Sarrià (IQS), Universitat Ramon Llull (URL), Barcelona, Spain.
Fernández-Varo G; Biochemistry and Molecular Genetics Service, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
Moreno-Lanceta A; Biochemistry and Molecular Genetics Service, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Department of Biomedicine, University of Barcelona, Barcelona, Spain.
García-Pérez R; Hepatopancreatobiliary Surgery & Transplantation, General & Digestive Surgery Service, Digestive & Metabolic Disease Institute (ICMDM) of Hospital Clínic of Barcelona, Barcelona, Spain. Department of Medicine, University of Barcelona, Barcelona, Spain.
Faneca J; Biochemistry and Molecular Genetics Service, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
López-Moya M; Grup d'Enginyeria de Materials (Gemat), Institut Químic de Sarrià (IQS), Universitat Ramon Llull (URL), Barcelona, Spain.
Fornaguera C; Grup d'Enginyeria de Materials (Gemat), Institut Químic de Sarrià (IQS), Universitat Ramon Llull (URL), Barcelona, Spain.
García-Villoria J; Biochemistry and Molecular Genetics Service, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Morales-Ruiz M; Biochemistry and Molecular Genetics Service, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain; Department of Biomedicine, University of Barcelona, Barcelona, Spain.
Melgar-Lesmes P; Biochemistry and Molecular Genetics Service, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain; Department of Biomedicine, University of Barcelona, Barcelona, Spain; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, USA.
Borrós S; Grup d'Enginyeria de Materials (Gemat), Institut Químic de Sarrià (IQS), Universitat Ramon Llull (URL), Barcelona, Spain.
Jiménez W; Biochemistry and Molecular Genetics Service, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain; Department of Biomedicine, University of Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Feb; Vol. 171, pp. 116143. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension, Portal*/drug therapy
Liver Cirrhosis, Experimental*/metabolism
Nanoparticles*
Rats ; Humans ; Animals ; Nitric Oxide/metabolism ; Liver ; Nitric Oxide Donors/pharmacology ; Liver Cirrhosis/drug therapy
Czasopismo naukowe
Tytuł:
Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteria.
Autorzy:
Ding D; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Guo G; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Cui L; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Jia G; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Wang X; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Zhang M; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Tian S; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Zheng L; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Liu Y; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Hu Y; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Xuan G; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Yang J; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Yang C; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Sun R; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Deng J; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Guo C; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China.
Chen Y; Fourth Department of Liver Disease (Difficult & Complicated Liver Diseases and Artificial Liver Center), Beijing You'an Hospital Affiliated to Capital Medical University, Beijing, China. .
Shang Y; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China. .
Han Y; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, The Air Force Military Medical University, Xi'an, 710032, Shaanxi, China. .
Pokaż więcej
Źródło:
Hepatology international [Hepatol Int] 2024 Feb; Vol. 18 (1), pp. 206-215. Date of Electronic Publication: 2023 Sep 19.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Cirrhosis, Biliary*/complications
Liver Cirrhosis, Biliary*/diagnostic imaging
Liver Cirrhosis, Biliary*/pathology
Esophageal and Gastric Varices*/complications
Elasticity Imaging Techniques*
Humans ; Liver Cirrhosis/complications ; Prognosis ; Liver/diagnostic imaging ; Liver/pathology
Czasopismo naukowe
Tytuł:
IL-21, not IL-17A, exacerbates murine primary biliary cholangitis.
Autorzy:
Chan CW; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chen HW; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Wang YW; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Lin CI; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chuang YH; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło:
Clinical and experimental immunology [Clin Exp Immunol] 2024 Feb 07; Vol. 215 (2), pp. 137-147.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Cirrhosis, Biliary*
Cholangitis*/pathology
Autoimmune Diseases*/pathology
Animals ; Mice ; Interleukin-17 ; Xenobiotics ; Interleukins ; Cytokines ; Fibrosis ; Liver Cirrhosis ; Inflammation
Czasopismo naukowe
Tytuł:
Hepatobiliary and Pancreatic: Challenges in the diagnosis of hepatic nodules in patients with alcoholic liver cirrhosis.
Autorzy:
Cho MS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Lee SK; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Kwon JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Nam SW; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2023 Nov; Vol. 38 (11), pp. 1867. Date of Electronic Publication: 2023 Jul 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Liver Cirrhosis, Alcoholic*/complications
Liver Cirrhosis, Alcoholic*/diagnosis
Liver Cirrhosis, Alcoholic*/pathology
Liver Neoplasms*/pathology
Humans ; Liver Cirrhosis/diagnostic imaging ; Liver Cirrhosis/etiology ; Pancreas ; Liver/pathology
Czasopismo naukowe
Tytuł:
Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center.
Autorzy:
Nejad SEM; Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Heiat M; Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Javanbakht M; Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Alavian SM; Middle East Liver Diseases (MELD) Center, Tehran, Iran.
Haris MAA; Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Jan 04; Vol. 24 (1), pp. 17. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Cirrhosis, Biliary*/diagnosis
Liver Cirrhosis, Biliary*/drug therapy
Liver Diseases*
Autoimmune Diseases*
Hepatitis, Autoimmune*/complications
Hepatitis, Autoimmune*/diagnosis
Hepatitis, Autoimmune*/drug therapy
Cholangitis, Sclerosing*/complications
Cholangitis, Sclerosing*/diagnosis
Cholangitis, Sclerosing*/drug therapy
Humans ; Retrospective Studies ; Alkaline Phosphatase ; Iran ; Liver Cirrhosis
Czasopismo naukowe
Tytuł:
Developing a Prognostic Model for Primary Biliary Cholangitis Based on a Random Survival Forest Model.
Autorzy:
Fu XY; Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Song YQ; Department of Gastroenterology, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Lin JY; Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Wang Y; Department of Gastroenterology, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Wu WD; Department of Gastroenterology, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Peng JB; Department of Gastroenterology, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Ye LP; Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Chen K; Taizhou Chinese Traditional Hospital, Jiaojiang, Zhejiang, China.
Li SW; Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.; Department of Gastroenterology, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.; Institute of Digestive Disease, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Pokaż więcej
Źródło:
International journal of medical sciences [Int J Med Sci] 2024 Jan 01; Vol. 21 (1), pp. 61-69. Date of Electronic Publication: 2024 Jan 01 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Liver Cirrhosis, Biliary*/diagnosis
Liver Cirrhosis, Biliary*/drug therapy
Humans ; Prognosis ; Ursodeoxycholic Acid/therapeutic use ; Retrospective Studies ; Liver Cirrhosis/drug therapy
Czasopismo naukowe
Tytuł:
The Influence of Hepatic Steatosis and Fibrosis on Postoperative Outcomes After Major Liver Resection of Perihilar Cholangiocarcinoma.
Autorzy:
van Keulen AM; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. .
Olthof PB; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Buettner S; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Bednarsch J; Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.
Verheij J; Department of Pathology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Erdmann JI; Department of Surgery, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Nooijen LE; Department of Surgery, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Porte RJ; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Minnee RC; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Murad SD; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Neumann UP; Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.; Department of Surgery, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands.
Heij L; Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany.; Department of Surgery, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands.; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.
Groot Koerkamp B; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Doukas M; Department of Surgery, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands. .
Pokaż więcej
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2024 Jan; Vol. 31 (1), pp. 133-141. Date of Electronic Publication: 2023 Oct 29.
Typ publikacji:
Journal Article
MeSH Terms:
Klatskin Tumor*/surgery
Liver Cirrhosis, Biliary*/complications
Liver Cirrhosis, Biliary*/surgery
Liver Failure*/etiology
Liver Neoplasms*/surgery
Fatty Liver*
Cholangitis*/complications
Cholangitis*/surgery
Bile Duct Neoplasms*/complications
Humans ; Aged ; Postoperative Complications ; Hepatectomy/adverse effects ; Liver Cirrhosis/complications ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Prevalence and prognostic significance of main metabolic risk factors in primary biliary cholangitis: a retrospective cohort study of 789 patients.
Autorzy:
Zhao DT; Clinical Laboratory Center and Clinical Research Center for Autoimmune Liver Disease, Beijing You'An Hospital, Capital Medical University, Beijing, China.
Yan HP; Clinical Laboratory Center and Clinical Research Center for Autoimmune Liver Disease, Beijing You'An Hospital, Capital Medical University, Beijing, China.; Second Department of Liver Disease Center, Beijing You'An Hospital, Capital Medical University, Beijing, China.
Han Y; Second Department of Liver Disease Center, Beijing You'An Hospital, Capital Medical University, Beijing, China.
Zhang WM; Department of Clinical Laboratory Diagnosis, Beijing You'An Hospital, Capital Medical University, Beijing, China.
Zhao Y; Clinical Laboratory Center and Clinical Research Center for Autoimmune Liver Disease, Beijing You'An Hospital, Capital Medical University, Beijing, China.; Clinical Laboratory Center, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Liao HY; Second Department of Liver Disease Center, Beijing You'An Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Nov 08; Vol. 14, pp. 1142177. Date of Electronic Publication: 2023 Nov 08 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Cirrhosis, Biliary*/complications
Liver Cirrhosis, Biliary*/epidemiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Hyperlipidemias*/epidemiology
Hyperlipidemias*/complications
Hypertension*/epidemiology
Hypertension*/complications
Humans ; Middle Aged ; Prognosis ; Retrospective Studies ; Prevalence ; Liver Cirrhosis/complications ; Risk Factors ; Fibrosis
Czasopismo naukowe
Tytuł:
Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study.
Autorzy:
Ludz C; Facoltà di Scienze Biomediche, Università della Svizzera Italiana, Lugano, Switzerland.
Stirnimann G; Universitätsklinik für Viszerale Chirurgie und Medizin, Inselspital Bern, Bern, Switzerland.
Semela D; Klinik für Gastroenterologie und Hepatologie, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Mertens J; GastroZentrum Hirslanden, Zürich, Switzerland.
Kremer AE; Klinik für Gastroenterologie und Hepatologie, Universitätsspital Zürich, Zürich, Switzerland.
Filipowicz Sinnreich M; Clinic for Gastroenterology and Hepatology, Medizinische Universitätsklinik, Kantonsspital Baselland, Liestal, Switzerland.
Sokollik C; Departement Pädiatrische Gastroenterologie, Hepatologie und Ernährung, Kinderklinik Inselspital Bern, Bern Switzerland.
Bernsmeier C; Gastroenterologie/Hepatologie, Universitäres Bauchzentrum Basel Clarunis, Basel, Switzerland.
Bresson-Hadni S; Service de Gastroentérologie and Hépatologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
McLin V; Département de l'Enfant et de l'Adolescent, Centre Suisse des Maladies du Foie de l'Enfant, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
Rock N; Département de l'Enfant et de l'Adolescent, Centre Suisse des Maladies du Foie de l'Enfant, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
Braegger C; Division of Pediatric Gastroenterology and Nutrition, University Children's Hospital Zurich, Zurich, Switzerland.
Posovszky C; Nutrition Research Unit, University Children's Hospital Zurich, Zurich, Switzerland.
Müller P; Departement pädiatrische Gastroenterologie und Hepatologie, Ostschweizer Kinderspital, St. Gallen, Switzerland.
Cremer M; Departement für Kinder- und Jugendmedizin, Kantonsspital Graubünden, Chur, Switzerland.
De Gottardi A; Servizio di Gastroenterologia, Ente Ospedaliero Cantonale Ospedale Regionale di Lugano, Lugano, Switzerland.
Galante A; Servizio di Gastroenterologia, Ente Ospedaliero Cantonale Ospedale Regionale di Lugano, Lugano, Switzerland.
Furlano R; University Children's Hospital Basel, Paediatric Gastroenterology and Nutrition, Basel, Switzerland.
Righini-Grunder F; Departement pädiatrische Gastroenterologie, Luzerner Kantonsspital/Kinderspital, Lucerne, Switzerland.
Becker B; Departement Innere Medizin, Klinik für Gastroenterologie und Hepatologie, Kantonsspital Winterthur, Winterthur, Switzerland.
Böhm S; Departement Gastroenterologie und Hepatologie, Klinik Innere Medizin, Spital Bülach, Bülach, Switzerland.
Heyland K; Departement Kindergastroenterologie, Kantonsspital Winterthur, Winterthur, Switzerland.
Nydegger A; Département femme-mère-enfant, Centre hospitalier universitaire Vaudois, Lausanne, Switzerland.
Limoni C; University of Applied Sciences and Arts of Southern Switzerland, Lugano, Switzerland.
Vergani D; MowatLabs, Faculty of Life Sciences and Medicine, King's College London, King's College Hospital, London, UK.
Mieli-Vergani G; MowatLabs, Faculty of Life Sciences and Medicine, King's College London, King's College Hospital, London, UK.
Di Bartolomeo C; Epatocentro Ticino, Lugano, Switzerland.
Cerny A; Epatocentro Ticino, Lugano, Switzerland.
Terziroli Beretta-Piccoli B; Facoltà di Scienze Biomediche, Università della Svizzera Italiana, Lugano, Switzerland.; MowatLabs, Faculty of Life Sciences and Medicine, King's College London, King's College Hospital, London, UK.; Epatocentro Ticino, Lugano, Switzerland.
Pokaż więcej
Źródło:
Swiss medical weekly [Swiss Med Wkly] 2023 Aug 31; Vol. 153, pp. 40102. Date of Electronic Publication: 2023 Aug 31.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis, Autoimmune*/complications
Hepatitis, Autoimmune*/diagnosis
Hepatitis, Autoimmune*/drug therapy
Liver Cirrhosis, Biliary*/complications
Liver Cirrhosis, Biliary*/drug therapy
Inflammatory Bowel Diseases*/drug therapy
Adult ; Humans ; Child ; Female ; Infant ; Child, Preschool ; Adolescent ; Middle Aged ; Male ; Azathioprine/therapeutic use ; Retrospective Studies ; Prospective Studies ; Switzerland/epidemiology ; Cohort Studies ; Mycophenolic Acid/therapeutic use ; Liver Cirrhosis ; Budesonide/therapeutic use
Czasopismo naukowe
Tytuł:
Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosis.
Autorzy:
ONeill JP; Department of Histopathology, St Vincent's University Hospital, Dublin, D04 T6F4, Ireland.
Clifford CS; Liver Unit, St Vincent's University Hospital, Dublin, D04 T6F4, Ireland.
Nolan NP; Department of Histopathology, St Vincent's University Hospital, Dublin, D04 T6F4, Ireland.; University College Dublin, Dublin, D04 V1W8, Ireland.
McCormick PA; Liver Unit, St Vincent's University Hospital, Dublin, D04 T6F4, Ireland. .; University College Dublin, Dublin, D04 V1W8, Ireland. .
Pokaż więcej
Źródło:
Irish journal of medical science [Ir J Med Sci] 2023 Aug; Vol. 192 (4), pp. 1657-1660. Date of Electronic Publication: 2022 Sep 17.
Typ publikacji:
Journal Article
MeSH Terms:
Cystic Fibrosis*/complications
Liver Cirrhosis, Biliary*/complications
Cholangitis, Sclerosing*/complications
Hypertension, Portal*/complications
Hypertension, Portal*/pathology
Adult ; Humans ; Hyperplasia/complications ; Liver Cirrhosis/complications ; Liver Cirrhosis/pathology
Czasopismo naukowe
Tytuł:
Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis.
Autorzy:
Jin Y; Department of Clinical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, Zhejiang, China.
Wang M
Liu Y
Xu A
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2023 Oct 20; Vol. 102 (42), pp. e35617.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Cirrhosis, Biliary*/complications
Animals ; Rats ; Humans ; Autoantibodies ; Retrospective Studies ; Liver Cirrhosis/complications ; Immunoassay
Czasopismo naukowe
Tytuł:
Systematic review and meta-analysis: Transient elastography compared to liver biopsy for staging of liver fibrosis in primary biliary cholangitis.
Autorzy:
Manzo-Francisco LA; Obesity and Digestive Diseases Unit, Medica Sur Hospital, Mexico City, Mexico.
Aquino-Matus J; Obesity and Digestive Diseases Unit, Medica Sur Hospital, Mexico City, Mexico.
Vidaña-Pérez D; Center for Research Evaluation and Surveys, National Institute of Public Health, Mexico City, Mexico.
Uribe M; Obesity and Digestive Diseases Unit, Medica Sur Hospital, Mexico City, Mexico.
Chavez-Tapia N; Obesity and Digestive Diseases Unit, Medica Sur Hospital, Mexico City, Mexico.. Electronic address: .
Pokaż więcej
Źródło:
Annals of hepatology [Ann Hepatol] 2023 Jul-Aug; Vol. 28 (4), pp. 101107. Date of Electronic Publication: 2023 Apr 23.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Elasticity Imaging Techniques*/methods
Liver Cirrhosis, Biliary*/diagnostic imaging
Liver Cirrhosis, Biliary*/pathology
Adult ; Humans ; Biopsy ; Fibrosis ; Liver/diagnostic imaging ; Liver/pathology ; Liver Cirrhosis/diagnostic imaging ; Liver Cirrhosis/etiology ; ROC Curve
Czasopismo naukowe
Tytuł:
Overlap syndrome of autoimmune hepatitis and primary biliary cholangitis complicated with atypical hepatocellular carcinoma: a case report.
Autorzy:
Surdea-Blaga T; 'Iuliu Hațieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.; 2nd Department of Internal Medicine, County Emergency Hospital, Cluj-Napoca, Romania.
Cărăguț RL; Regional Institute of Gastroenterology and Hepatology, No. 19-21 Croitorilor Street, 400162, Cluj-Napoca, Cluj, Romania. .
Caraiani C; 'Iuliu Hațieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Spârchez Z; 'Iuliu Hațieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Regional Institute of Gastroenterology and Hepatology, No. 19-21 Croitorilor Street, 400162, Cluj-Napoca, Cluj, Romania.
Al Hajjar N; 'Iuliu Hațieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.; Regional Institute of Gastroenterology and Hepatology, No. 19-21 Croitorilor Street, 400162, Cluj-Napoca, Cluj, Romania.
Dumitrașcu DL; 'Iuliu Hațieganu' University of Medicine and Pharmacy, Cluj-Napoca, Romania.; 2nd Department of Internal Medicine, County Emergency Hospital, Cluj-Napoca, Romania.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Jul 25; Vol. 17 (1), pp. 328. Date of Electronic Publication: 2023 Jul 25.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hepatitis, Autoimmune*
Carcinoma, Hepatocellular*
Liver Cirrhosis, Biliary*
Liver Neoplasms*
Connective Tissue Diseases*
Humans ; Female ; Aged ; Liver Cirrhosis
Czasopismo naukowe
Tytuł:
Late evening snack and oral amino acid capsules improved respiratory quotient and Fischer ratio in patients with alcoholic liver cirrhosis.
Autorzy:
Zhao J; Second Department of Liver Disease Centre, Beijing Youan Hospital, Capital MedicalUniversity, Beijing, 100069, China.
Wu J; Department of Medical Oncology, Beijing Youan Hospital(,) Capital Medical University(,) Beijing, 100069, China.
Li J; Department of Respiratory and Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Wang ZY; Department of Respiratory and Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Meng QH; Department of Medical Oncology, Beijing Youan Hospital(,) Capital Medical University(,) Beijing, 100069, China. Electronic address: meng_.
Pokaż więcej
Źródło:
Annals of hepatology [Ann Hepatol] 2023 Jul-Aug; Vol. 28 (4), pp. 100750. Date of Electronic Publication: 2022 Aug 23.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Liver Cirrhosis, Alcoholic*
Amino Acids*
Humans ; Liver Cirrhosis/metabolism ; Snacks ; Capsules ; Isoleucine
Czasopismo naukowe
Tytuł:
Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome.
Autorzy:
Braga MH; Departamento de Gastroenterologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Cançado GGL; Instituto Alfa de Gastroenterologia, Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Hospital da Polícia Militar de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. Electronic address: .
Bittencourt PL; Escola Bahiana de Medicina e Saúde Pública, Salvador, Bahia, Brazil; Hospital Português, Salvador, Bahia, Brazil.
Couto CA; Instituto Alfa de Gastroenterologia, Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Guedes LV; Departamento de Gastroenterologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Lima AMC; Instituto Alfa de Gastroenterologia, Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Ferraz MLG; Disciplina de Gastroenterologia, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.
Villela-Nogueira CA; Hospital Universitário Clementino Fraga Filho e Departamento de Clínica Médica da Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
Nardelli MJ; Instituto Alfa de Gastroenterologia, Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Faria LC; Instituto Alfa de Gastroenterologia, Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Gomes NMF; Disciplina de Gastroenterologia, Universidade Federal de São Paulo, São Paulo, São Paulo, Brazil.
Oliveira EMG; Centro Universitário Lusíada - UNILUS, Santos, São Paulo, Brazil.
Rotman V; Hospital Universitário Clementino Fraga Filho e Departamento de Clínica Médica da Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
Oliveira MB; Ambulatório Municipal de Hepatites Virais de São José dos Campos, São José dos Campos, São Paulo, Brazil.
da Cunha SMCF; Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brazil.
Cunha-Silva M; Divisão de Gastroenterologia (Gastrocentro), Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.
Mendes LSC; Hospital de Base do Distrito Federal, Brasília, Distrito Federal, Brazil.
Ivantes CAP; Serviço de Gastroenterologia, Hepatologia e Transplante Hepático, Hospital Nossa Senhora das Graças, Curitiba, Paraná, Brazil.
Codes L; Hospital Português, Salvador, Bahia, Brazil.
de Almeida E Borges VF; Instituto de Gastroenterologia, Endoscopia e Proctologia, Uberlândia, Minas Gerais, Brazil; Universidade Federal de Uberlândia, Uberlândia, Minas Gerais, Brazil.
Pace FHL; Serviço de Gastroenterologia e Hepatologia, Universidade Federal de Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Pessoa MG; Departamento de Gastroenterologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Signorelli IV; Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brazil.
Coral GP; Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Filho JG; Instituto Alfa de Gastroenterologia, Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Chagas AL; Departamento de Gastroenterologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Terrabuio DRB; Departamento de Gastroenterologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Cançado ELR; Departamento de Gastroenterologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Pokaż więcej
Corporate Authors:
Members of the Brazilian Cholestasis Study Group Consortium
Źródło:
Annals of hepatology [Ann Hepatol] 2023 Jul-Aug; Vol. 28 (4), pp. 101105. Date of Electronic Publication: 2023 Apr 23.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis, Autoimmune*/complications
Hepatitis, Autoimmune*/diagnosis
Hepatitis, Autoimmune*/epidemiology
Liver Cirrhosis, Biliary*/diagnosis
Liver Cirrhosis, Biliary*/epidemiology
Liver Cirrhosis, Biliary*/complications
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/complications
Liver Neoplasms*/epidemiology
Liver Neoplasms*/complications
Humans ; Azathioprine/therapeutic use ; Liver Cirrhosis/complications ; Risk Factors ; Syndrome ; Obesity/complications
Czasopismo naukowe
Tytuł:
Role of Nitric Oxide in the Altered Calcium Homeostasis of Platelets from Rats with Biliary Cirrhosis.
Autorzy:
Akbari Aghdam M; Departamento de Fisiología, Facultad de Medicina, Instituto Murciano de Investigación Biosanitaria, Universidad de Murcia, 30120 Murcia, Spain.
Romecín P; Departamento de Fisiología, Facultad de Medicina, Instituto Murciano de Investigación Biosanitaria, Universidad de Murcia, 30120 Murcia, Spain.
García-Estañ J; Departamento de Fisiología, Facultad de Medicina, Instituto Murciano de Investigación Biosanitaria, Universidad de Murcia, 30120 Murcia, Spain.
Atucha NM; Departamento de Fisiología, Facultad de Medicina, Instituto Murciano de Investigación Biosanitaria, Universidad de Murcia, 30120 Murcia, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 30; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 30.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Cirrhosis, Biliary*
Rats ; Animals ; Nitric Oxide/therapeutic use ; Blood Platelets ; Calcium ; Rats, Sprague-Dawley ; NG-Nitroarginine Methyl Ester/pharmacology ; Thrombin/pharmacology ; Thrombin/therapeutic use ; Liver Cirrhosis/drug therapy ; Ligation
Czasopismo naukowe
Tytuł:
Changes in Macrophage Subpopulations in Rat Liver at Different Stages of Experimental Fibrosis.
Autorzy:
Lebedeva EI; Vitebsk State Order of Peoples' Friendship Medical University, Vitebsk, Belarus. .
Pokaż więcej
Źródło:
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2023 Jun; Vol. 175 (2), pp. 279-285. Date of Electronic Publication: 2023 Jul 21.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Cirrhosis, Experimental*/chemically induced
Rats ; Animals ; Rats, Wistar ; Liver/pathology ; Liver Cirrhosis/chemically induced ; Liver Cirrhosis/pathology ; Macrophages/pathology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies